Complete Response of Recurrent Small Cell Carcinoma of the Uterine Cervix to Paclitaxel, Carboplatin, and Bevacizumab Combination Therapy

We report a case of recurrent small cell carcinoma of the uterine cervix that showed a complete response to paclitaxel, carboplatin, and bevacizumab (TC + Bev) combination therapy. Small cell carcinoma of the uterine cervix is extremely rare, with an incidence of only 1.3% in Japan, and a poor outco...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakao, Yuri, Tamauchi, Satoshi, Yoshikawa, Nobuhisa, Suzuki, Shiro, Kajiyama, Hiroaki, Kikkawa, Fumitaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184850/
https://www.ncbi.nlm.nih.gov/pubmed/32355492
http://dx.doi.org/10.1159/000506446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184850/
https://www.ncbi.nlm.nih.gov/pubmed/32355492
http://dx.doi.org/10.1159/000506446

Ejemplares similares